Navigation Links
HPV Test Beats Pap Smear for Cancer Screening
Date:4/28/2010

Newer method better at detecting precancerous lesions, research shows

WEDNESDAY, April 28 (HealthDay News) -- Doctors can detect more serious precancerous lesions in the cervix by testing for human papillomavirus (HPV) than through conventional cervical screening with a Pap smear, a new study suggests.

HPV, a common sexually transmitted disease, can cause cancers such as cervical cancer. The disease is especially prevalent in young women.

In the new study, led by Ahti Anttila of the Finnish Cancer Registry, researchers studied the experiences of 58,282 women aged 30 to 60 who took part in routine cervical screening between 2003 and 2005.

The women were randomly assigned to receive an HPV test or a Pap smear test. The researchers then tracked the women for five years.

The HPV screening tests did a better job at detecting serious precancerous lesions on the surface of the cervix, known as cervical intraepithelial neoplasia (CIN III), according to the report published online April 28 in the BMJ.

The researchers cautioned that they didn't detect very many cervical cancer cases. Still, they wrote, "considering the high probability of progression of CIN III lesions in women aged 35 years or more, our results are important for prevention of cervical cancer."

More information

The U.S. National Cancer Institute has more on cervical cancer.



-- Randy Dotinga



SOURCE: BMJ, news release, April 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Newer Blood Thinner Beats Plavix for Bypass Patients
2. Burning Heart Tissue Beats Atrial Fibrillation
3. Lithium Beats Valproate for Long-Term Bipolar Therapy
4. Should HPV Test Replace the Pap Smear?
5. Quick new screening exam could save thousands of people from bowel cancer
6. One Sigmoidoscopy Boosts Colon Cancer Survival Odds
7. Imaging costs rising faster than total cancer care for Medicare
8. Cell study finds receptor can fight tamoxifen-resistant breast cancer cells
9. Use and costs of diagnostic imaging increasing for patients with cancer
10. Imaging Costs Soar for Medicare Cancer Patients
11. Selenium Helped Cells Reboot After Exposure to Cancer-Causing Chemicals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding them ... a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to provide ... need to turn on a light when taking medication during the night, allowing the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: